The present disclosure relates to devices and methods for identifying conditions in a human or animal body, such as pregnancy or ovulation. For example, the present disclosure relates to devices and methods for identifying pregnancy or ovulation, which devices and methods are adapted to mitigate the “hook effect”, thereby improving accuracy of the devices and methods.

A vaginal insert device and method of use for improving and preventing symptoms associated with pelvic organ prolapse and urinary and/or fecal incontinence, administer medication or topical treatment, and/or collect a sample when the device is inserted, or any combination thereof. The vaginal insert device may be cone-shaped, may have a removal portion, may have external ridges, may have internal ribs, may have an open or closed top, or combinations thereof. The device may include cavities, diagnostic devices, and/or microchips.

The present disclosure generally relates to cycle tracking. A notification for a respective recurrence of the recurring event is displayed. Representations of days are displayed with affordances for initiating processes for recording information corresponding to various days.

Provided are systems for grouping users who have chosen to participate into one of a plurality of menstrual cycle groups based on data provided by and/or collected from those users. In some examples, a wearable computing device can include one or more sensors that can measure one or more physiological signals associated with the user. Based on the physiological signals gathered from the one or more sensors, the wearable computing device can determine biometric data for one or more users. Furthermore, the wearable computing device can enable a user to submit information about their menstrual cycle (e.g., via an interactive touch screen). These factors can be used to automatically determine some menstrual cycle data for a user.

Exemplary embodiments account for differing needs of a user over the menstrual cycle of the user to better control the blood glucose concentration of the user. The exemplary embodiments may be realized in control systems for medicament delivery devices that deliver medicaments, such as medicaments that regulate blood glucose concentration levels. Examples of such medicaments that regulate blood glucose concentration levels include insulin, glucagon, and glucagon peptide-1 (GLP-1) agonists. The exemplary embodiments are able to better tailor the dosages of the medicament delivered to the user with the medicament delivery device to reduce the risk of hyperglycemia and hypoglycemia and help reduce blood glucose concentration excursions.

The invention relates to a system (4) for estimating a fertility status of a woman, particularly for determining a conception probability of a woman, the system (4) comprising:—A wearable device (2A, 2B), comprising at least one sensor (201, 203, 204) configured to record at least one physiological signal from a woman wearing the wearable device (2A, 2B) and to generate sensor data from the at least one physiological signal, wherein the wearable device (2A, 2B) is configured and arranged to provide the sensor data to—An evaluation system (1) configured and arranged to receive and process the sensor data from the wearable device (2A, 2B), wherein the evaluation system (1) is further configured and arranged to classify the sensor data into at least a first group and a second group, wherein the first group is associated to sensor data indicative of a woman having a high fertility status and wherein the second group is associated to sensor data indicative of a woman having a low fertility status.

The present invention relates to a body fluid observation device which enables observation of a user's body fluid. A body fluid observation device according to an example of the present invention comprises: a chamber which has a length in a first horizontal direction and in which a body fluid of a user is stably placed; and a body into which the chamber is inserted for observation of the body fluid. The body comprises: a case including a chamber insertion hole which is formed through the front surface of the body and into which the chamber is inserted, a guide partition wall extending from the chamber insertion hole in the first horizontal direction to guide the chamber, and an observation hole provided through the bottom surface of the body to allow observation of the body fluid; a light source part which is positioned above the chamber in the case and emits light; and an operation part electrically connected to the light source part to operate the light source part, wherein, as the chamber is inserted into the chamber insertion hole, the operation part can form an electrically closed loop for operating the light source part.

Methods, systems, and devices for illness detection are described. A method may include identifying a menstrual cycle model associated with a menstrual cycle for a user, and receiving physiological data for the user collected throughout a first time interval and a second time interval by a wearable device. The method may include inputting the physiological data and the menstrual cycle model into a classifier, and identifying a satisfaction of deviation criteria between first and second subsets of the physiological data collected throughout the first and second time intervals, respectively, based on the menstrual cycle model. The method may include causing a graphical user interface (GUI) of a user device to display an illness risk metric associated with the user based on the satisfaction of the deviation criteria, the illness risk metric associated with a relative probability that the user will transition from a healthy state to an unhealthy state.

A fertility kit for performing self-insemination, comprising a package with three sets of sterilized disposable syringes and collection jars. Each fertility syringe comprises: an outer rigid tubular barrel and an inner plunger. The barrel comprises a curved distal end with a small circular distal opening, and a sealed proximal end, and an inner hollow tube housing the plunger. The barrel's proximal end also comprises two opposing circular members to fit a user's fingers; and a plunger flat end fitting in-between. The plunger distal end has a has a funnel-like shape that fits into the barrel curved end to push all the semen out while preventing a backflow. The collection jar comprises a sealable lid, and an inner surface comprising smooth seamless edges. Fresh or frozen, unwashed semen is deposited into the jar, pulled into the syringe, and administered cervically during a user's maximum monthly level of luteinizing hormone.

A mechanism for estimating windows for menstrual cycles and fertility. The mechanism tracks menstrual cycles based on accuracy of predictions as compared to user input logging the start and stop of a cycle; this user input and the accuracy of prior cycle predictions is used to improve and update future predictions. Thus, as the mechanism receives additional data, it refines its predicted fertility window and period. A user's heart rate may be used to estimate fertility windows, periods, and other portions of a menstrual cycle.